Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis.

导出 OA

翻译打印收藏纠错

第一作者： Siri,Lillegraven

第一单位： Diakonhjemmet Hospital, Oslo, Norway.

作者： Siri,Lillegraven ^[1] ; Jeffrey D,Greenberg ^[2] ; George W,Reed ^[3] ; Katherine,Saunders ^[4] ; Jeffrey R,Curtis ^[5] ; Leslie,Harrold ^[6] ; Marc C,Hochberg ^[3] ; Dimitrios A,Pappas ^[7] ; Joel M,Kremer ^[8] ; Daniel H,Solomon ^[9]

作者单位： Diakonhjemmet Hospital, Oslo, Norway. ^[1] NYU Hospital for Joint Diseases, New York, New York, United States of America. ^[2] Corrona, LLC, Worcester, Massachusetts, United States of America. ^[3] UMass Medical School, Worcester, Massachusetts, United States of America. ^[4] Corrona, LLC., Southborough, Massachusetts, United States of America. ^[5] University of Alabama at Birmingham, Birmingham, AL, United States of America. ^[6] University of Massachusetts Medical School, Worcester, Massachusetts, United States of America. ^[7] University of Maryland School of Medicine, Baltimore, MD, United States of America. ^[8] Columbia University, College of Physicians and Surgeons, New York, NY, United States of America. ^[9] Albany Medical College and The Center for Rheumatology, Albany, NY, United States of America. ^[10] Brigham and Women's Hospital, Boston, Massachusetts, United States of America. ^[11]